Partner with FINNCURE

FINNCURE collaborates with pharmaceutical and biotech companies to improve how therapies are delivered.
We integrate partner compounds into our tailored carrier systems designed to improve stability,
bioavailability, and precision, without modifying the compound itself.

What We Can Do for Partners

Depending on the compound and its development needs, FINNCURE’s technology can be used to:

Improve targeting and biodistribution:

Increase delivery to the intended cells and tissues while reducing exposure elsewhere in the body.

Enhance cellular uptake:

Increase the amount of therapeutic compound delivered into intended target cells.

Create new opportunities for existing compounds:

Incorporating an existing therapeutic compound into FINNCURE’s carrier system can create opportunities for additional patent protection.

We typically start by assessing the compound, target, and intended application. Based on this, we develop and test a suitable carrier. Depending on the project, the collaboration can move to further development or licensing.

Partner Network

FINNCURE works with a broad network of collaborators, stakeholders, and service providers across research, preclinical development, clinical validation, and intellectual property management

The partner network includes:

We are currently seeking pilot collaboration opportunities with pharmaceutical and biotech partners whose therapeutic compounds could benefit from improved targeting, cellular uptake, or reduced off-target exposure.

R&D Partnerships

Co-development Programs

Early Validation Projects

Licensing

Start a Conversation

Have a therapeutic compound with challenges in targeting, cellular uptake, or off-target exposure? Contact us to explore whether FINNCURE’s carrier platform could support its development.